Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Interest Coverage Ratio (2016 - 2017)

Historic Interest Coverage Ratio for CytomX Therapeutics (CTMX) over the last 4 years, with Q1 2017 value amounting to 41.82.

  • CytomX Therapeutics' Interest Coverage Ratio rose 878.21% to 41.82 in Q1 2017 from the same period last year, while for Dec 2017 it was 224.56, marking a year-over-year decrease of 53652.35%. This contributed to the annual value of 35.28 for FY2016, which is 8402.85% down from last year.
  • Latest data reveals that CytomX Therapeutics reported Interest Coverage Ratio of 41.82 as of Q1 2017, which was up 878.21% from 36.58 recorded in Q4 2016.
  • CytomX Therapeutics' 5-year Interest Coverage Ratio high stood at 13.58 for Q2 2015, and its period low was 45.84 during Q1 2016.
  • In the last 4 years, CytomX Therapeutics' Interest Coverage Ratio had a median value of 30.66 in 2016 and averaged 30.84.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first soared by 4698.86% in 2015, then tumbled by 12573.52% in 2016.
  • CytomX Therapeutics' Interest Coverage Ratio (Quarter) stood at 42.74 in 2014, then rose by 28.3% to 30.65 in 2015, then dropped by 19.35% to 36.58 in 2016, then fell by 14.31% to 41.82 in 2017.
  • Its last three reported values are 41.82 in Q1 2017, 36.58 for Q4 2016, and 30.95 during Q3 2016.